The Voigt Group and PHOENIX Pharma Switzerland have decided to bring their subsidiaries Voigt and Voigt Industrie Service and Amedis-UE respectively into a 50/50 joint venture. After receiving clearance from the Swiss Competition Commission, this closing
Tags :Frank Gerhard
Homburger advised allosteric modulation company Addex Therapeutics in Plan-les-Ouates, Geneva (SIX: ADXN) in the completion of an equity financing transaction with a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 7,999,998 shares
The controlling shareholder of Reuge, the renowned music box producer, successfully completed the sale of a majority stake in the Reuge manufacture to the Swiss luxury watchmaker De Bethune. The independent watchmaker, known for its
Dufry has successfully closed the transfer of the 50.3% stake in Autogrill held by Edizione through a wholly owned subsidiary to Dufry. Dufry will launch a mandatory public exchange offer for the remaining Autogrill shares (excluding
DKSH Holding will sell its 25% stake in Swiss luxury watchmaker Bovet to Pascal Raffy which makes him the watchmaker’s sole owner due that he owns already the 75% of Bovet Fleurier. Raffy, a former pharmaceutical
LatticeFLow, an ETH spin-off pioneering in robust artificial intelligence (AI) having built a system that can automatically find and fix AI data and model errors, announced a USD 12 m Series A funding round led by
PHOENIX Pharma Switzerland, a subsidiary of the family-owned PHOENIX group, and Voigt Holding announced that they agreed to establish a 50/50-joint venture to combine their pharmaceutical distribution services and pre-wholesale activities. The closing of the
DKSH Holding has acquired Terra Firma, a leading distributor of specialty chemicals in North America. With this acquisition, DKSH expands its performance materials business unit platform to the US and Canada. The transaction is an
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, has completed a USD 4,2 million equity financing. The allosteric modulation company Addex has entered into a definitive agreement with Armistice Capital, a
BlackFin Capital Partners has reported the sale of its portfolio company New Access, a Geneva-based private banking technology firm, to FNZ, a global wealth management platform with registered office in London. The acquisted New Access
